The National Pharmaceutical Pricing Authority (NPPA) has fixed retail prices for 30 drug formulations, including essential vitamins and medications for chronic conditions. This price fixation, made under the Drugs (Prices Control) Order (DPCO), 2013, includes notable formulations such as Vitamin D3 Oral Solution, priced at ₹14.91 per ml, and anti-diabetic combinations like Empagliflozin, Sitagliptin, and Metformin at ₹14.88 per tablet. Other medications include Atorvastatin and Fenofibrate for lipid management at ₹18.46 per tablet, and Tacrolimus for immunosuppressant therapy at ₹127 per capsule. The NPPA emphasized that these prices are exclusive of Goods and Services Tax (GST) and must be adhered to by manufacturers and retailers. Compliance is mandatory, with penalties for overcharging outlined under the DPCO, 2013 and the Essential Commodities Act, 1955. This notification supersedes all previous price orders for the specified formulations.